TARO PHARMACEUTICAL INDS LTD's ticker is TARO and the CUSIP is M8737E108. A total of 161 filers reported holding TARO PHARMACEUTICAL INDS LTD in Q3 2016. The put-call ratio across all filers is 0.69 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2017 | $8,000 | -20.0% | 74 | -14.9% | 0.00% | 0.0% |
Q3 2017 | $10,000 | 0.0% | 87 | 0.0% | 0.00% | 0.0% |
Q2 2017 | $10,000 | +11.1% | 87 | +7.4% | 0.00% | 0.0% |
Q1 2017 | $9,000 | +125.0% | 81 | +118.9% | 0.00% | 0.0% |
Q4 2016 | $4,000 | +100.0% | 37 | +105.6% | 0.00% | – |
Q3 2016 | $2,000 | – | 18 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
ISZO CAPITAL LP | 1,104,068 | $104,886,000 | 77.66% |
Greywolf Capital Management LP | 472,135 | $46,694,000 | 10.17% |
Consonance Capital Management LP | 263,732 | $26,083,000 | 4.28% |
Moab Capital Partners | 83,132 | $8,222,000 | 3.77% |
Raging Capital Management, LLC | 190,151 | $18,806,000 | 3.45% |
Valentine Capital Asset Management, Inc. | 145,053 | $14,346,000 | 3.07% |
Assured Investment Management LLC | 1,353,342 | $133,846,000 | 1.21% |
Ativo Capital Management LLC | 22,828 | $2,258,000 | 0.99% |
Perceptive Advisors | 56,602 | $5,598,000 | 0.67% |
Jaffetilchin Investment Partners, LLC | 7,721 | $764,000 | 0.38% |